The pandemic has caused a huge mindset shift in health care. An investor sees opportunities.

In the future, we won't be discovering new drugs or cures to cancer -- they will be designed by computers. And that process of bioengineering has only become more urgent as a result of the coronavirus pandemic and the need to find a solution fast. Vijay Pande, a partner at Andreessen Horowitz's biotech fund, has been investing at the intersection of health care, biology and computer science for the last five years. Coronavirus has amplified the need for this kind of technology, but the pandemic also played a more important role: shifting the mindset of patients and doctors alike. People have become more attuned to what they need to do to stay healthy, while doctors are more open trying to new technologies and techniques, Pande told Protocol.